KR0181740B1 - 약물 및 남용물질 탐닉의 치료용 약학적 제제 - Google Patents

약물 및 남용물질 탐닉의 치료용 약학적 제제 Download PDF

Info

Publication number
KR0181740B1
KR0181740B1 KR1019930702617A KR930702617A KR0181740B1 KR 0181740 B1 KR0181740 B1 KR 0181740B1 KR 1019930702617 A KR1019930702617 A KR 1019930702617A KR 930702617 A KR930702617 A KR 930702617A KR 0181740 B1 KR0181740 B1 KR 0181740B1
Authority
KR
South Korea
Prior art keywords
indole
piperidyl
fluorophenyl
acid
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019930702617A
Other languages
English (en)
Korean (ko)
Other versions
KR930702977A (ko
Inventor
크리스티안 페레가르트 젠스
코스탈 브렌다
Original Assignee
에바 스테인네스
하.룬트베크 아크티에 셀스카브
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에바 스테인네스, 하.룬트베크 아크티에 셀스카브 filed Critical 에바 스테인네스
Publication of KR930702977A publication Critical patent/KR930702977A/ko
Application granted granted Critical
Publication of KR0181740B1 publication Critical patent/KR0181740B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Apparatuses And Processes For Manufacturing Resistors (AREA)
  • Disintegrating Or Milling (AREA)
  • Medicinal Preparation (AREA)
KR1019930702617A 1991-03-01 1992-02-28 약물 및 남용물질 탐닉의 치료용 약학적 제제 Expired - Fee Related KR0181740B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK036391A DK36391D0 (da) 1991-03-01 1991-03-01 Anvendelse af piperidylsubstituerede indolderivater til behandling af stofmisbrug
DK363/91 1991-03-01
PCT/DK1992/000062 WO1992015302A1 (en) 1991-03-01 1992-02-28 Treatment of addiction to drugs and substances of abuse

Publications (2)

Publication Number Publication Date
KR930702977A KR930702977A (ko) 1993-11-29
KR0181740B1 true KR0181740B1 (ko) 1999-05-01

Family

ID=8092675

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930702617A Expired - Fee Related KR0181740B1 (ko) 1991-03-01 1992-02-28 약물 및 남용물질 탐닉의 치료용 약학적 제제

Country Status (16)

Country Link
US (1) US5462948A (da)
EP (1) EP0575430B1 (da)
JP (1) JP3332233B2 (da)
KR (1) KR0181740B1 (da)
AT (1) ATE169218T1 (da)
AU (1) AU661476B2 (da)
CA (1) CA2105384C (da)
DE (1) DE69226522T2 (da)
DK (2) DK36391D0 (da)
IE (1) IE920571A1 (da)
IL (1) IL101101A (da)
NO (1) NO304350B1 (da)
NZ (1) NZ241801A (da)
PH (1) PH30084A (da)
WO (1) WO1992015302A1 (da)
ZA (1) ZA921463B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK139593D0 (da) * 1993-12-16 1993-12-16 Lundbeck & Co As H Compounds
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US5824684A (en) * 1997-02-21 1998-10-20 Synapse Pharmaceuticals International, Inc. Method for treating drug and alcohol addiction
US6489341B1 (en) 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
WO2006117314A2 (en) * 2005-04-30 2006-11-09 Boehringer Ingelheim International Gmbh Novel piperidin- substituted indoles and their use as ccr-3 modulators
US20070212412A1 (en) * 2005-09-08 2007-09-13 H. Lundbeck A/S Stable solid formulation of sertindole
TW200821296A (en) * 2006-06-01 2008-05-16 Lundbeck & Co As H Use of sertindole for the preventive treatment of suicidal behaviour

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use

Also Published As

Publication number Publication date
DK36391D0 (da) 1991-03-01
JP3332233B2 (ja) 2002-10-07
IL101101A0 (en) 1992-11-15
JPH06505021A (ja) 1994-06-09
IE920571A1 (en) 1992-09-09
DE69226522D1 (de) 1998-09-10
AU661476B2 (en) 1995-07-27
NZ241801A (en) 1997-05-26
NO933090D0 (no) 1993-08-31
HK1009253A1 (en) 1999-08-13
AU1370692A (en) 1992-10-06
NO304350B1 (no) 1998-12-07
DE69226522T2 (de) 1999-01-07
CA2105384A1 (en) 1992-09-02
WO1992015302A1 (en) 1992-09-17
NO933090L (no) 1993-08-31
EP0575430B1 (en) 1998-08-05
PH30084A (en) 1996-12-27
ATE169218T1 (de) 1998-08-15
EP0575430A1 (en) 1993-12-29
ZA921463B (en) 1992-11-25
US5462948A (en) 1995-10-31
CA2105384C (en) 2000-09-12
KR930702977A (ko) 1993-11-29
IL101101A (en) 1996-03-31
DK0575430T3 (da) 1999-05-10

Similar Documents

Publication Publication Date Title
DK169674B1 (da) 1-Aryl-3-tetrahydropyridyl-, 1-aryl-3-piperidyl- eller 1-aryl-3-piperazinyl-indolderivater, fremgangsmåde til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
EP0533824B1 (en) Piperidyl-substituted indoles
EP0575430B1 (en) Preparation of a medicament for the treatment of addiction to drugs and substances of abuse
KR0183424B1 (ko) 인식력 장애 치료용 약학적 제제
CA2169804A1 (en) Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
WO1992015301A1 (en) Treatment of hypertension and peripheral vascular diseases
HK1009253B (en) Preparation of a medicament for the treatment of addiction to drugs and substances of abuse
HK1003560B (en) Treatment of cognitive disorders

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

FPAY Annual fee payment

Payment date: 20071123

Year of fee payment: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20081210

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20081210

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000